3 Big Pharmas That Could be Winners for Investors in the Long Run

Gemini Therapeutics Banks $42.5M to Bring Precisio

Gemini Therapeutics Banks $42.5M to Bring Precisio

Big pharma stocks have been longtime favorites among investors for several reasons.

Big pharma stocks have been longtime favorites among investors for several reasons. The fact that they’re big means that that they generate huge cash flow, which typically translates to attractive dividends. And big pharma companies operate in a growing industry, with demand for prescription drugs continuing to rise -- especially with expanding elderly populations across the world.

MORE ON THIS TOPIC